Baloxavir Marboxil 2% Granules in Japanese Children With Influenza: An Open-label Phase 3 Study

A granule formulation of baloxavir marboxil, a selective inhibitor of influenza cap-dependent endonuclease, was newly developed for children with difficulty swallowing tablets. METHODS: A multicenter open-label study was conducted during the 2017–2018 influenza season to assess the safety, pharmacok...

Descripción completa

Detalles Bibliográficos
Autores principales: Yokoyama, Takato, Sakaguchi, Hiroki, Ishibashi, Toru, Shishido, Takao, Piedra, Pedro A., Sato, Chisako, Tsuchiya, Kenji, Uehara, Takeki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2020
Materias:
Antimicrobial Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7360099/
https://www.ncbi.nlm.nih.gov/pubmed/32433222
http://dx.doi.org/10.1097/INF.0000000000002748

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7360099/
https://www.ncbi.nlm.nih.gov/pubmed/32433222
http://dx.doi.org/10.1097/INF.0000000000002748

Ejemplares similares